Baricitinib for the treatment of alopecia areata

E Freitas, E Guttman-Yassky, T Torres - Drugs, 2023 - Springer
Alopecia areata (AA) is a relapsing, chronic, immune-mediated disease characterized by
nonscarring, inflammatory hair loss that can affect any hair-bearing site. AA clinical …

Study of the thyroid profile of patients with alopecia

A Popa, M Carsote, D Cretoiu, MC Dumitrascu… - Journal of Clinical …, 2023 - mdpi.com
Thyroid hormones are required for the physiological growth and maintenance of hair
follicles. We aim to study the thyroid profile of patients with alopecia. This is a narrative …

Traditional Chinese Medicine Shi-Bi-Man regulates lactic acid metabolism and drives hair follicle stem cell activation to promote hair regeneration

H Du, T Zhang, Q Wang, X Cao, H Zheng, J Li, J Zhu… - Chinese Medicine, 2023 - Springer
Background As a supplement for promoting hair health, Shi-Bi-Man (SBM) is a prescription
comprising various traditional Chinese medicines. Though SBM has been reported to …

[HTML][HTML] Efficacy and safety of baricitinib in patients with alopecia areata: Evidence to date

S Faria, E Freitas, T Torres - Drugs in Context, 2023 - ncbi.nlm.nih.gov
Alopecia areata (AA) is a chronic, tissue-specific autoimmune disorder, characterized by non-
scaring hair loss, with a global prevalence of approximately 2%. Typically, it affects a young …

Physician-and patient-reported severity and quality of life impact of alopecia areata: results from a real-world survey in five European countries

S Vañó-Galván, U Blume-Peytavi, P Farrant… - Dermatology and …, 2023 - Springer
Introduction Alopecia areata (AA) can negatively affect quality of life (QoL) and is associated
with increased prevalence of anxiety and depression (vs people without AA). This study …

Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data

M Ohyama, K Kamei, A Yuasa… - The Journal of …, 2023 - Wiley Online Library
Alopecia area (AA) is a common autoimmune disorder, characterized by hair loss. Although
its impact on quality of life is fairly well understood, studies on the economic impact of AA are …

Molybdenum nanoparticles as a potential topical medication for alopecia treatment through antioxidant pathways that differ from minoxidil

Q Xiao, Y Lu, W Yao, CC Gong, C Jia, J Gao… - Journal of Trace …, 2024 - Elsevier
Background Hair loss is a common dermatological condition including various types such as
alopecia areata, androgenetic alopecia, etc. Minoxidil is a topical medication used for …

Modulation of hair growth by topical drug delivery enhanced by STAR particles

MR Woo, MR Prausnitz - Journal of Controlled Release, 2023 - Elsevier
Topical treatments to modulate hair growth are generally limited by low drug bioavailability
due to poor skin permeability. Here, we studied the use of STAR particles, which are …

Noval advance of histone modification in inflammatory skin diseases and related treatment methods

L Zhang, R Chai, Z Tai, F Miao, X Shi, Z Chen… - Frontiers in …, 2024 - frontiersin.org
Inflammatory skin diseases are a group of diseases caused by the disruption of skin tissue
due to immune system disorders. Histone modification plays a pivotal role in the …

Deciphering the Complex Immunopathogenesis of Alopecia Areata

I Šutić Udović, N Hlača, LP Massari, I Brajac… - International Journal of …, 2024 - mdpi.com
Alopecia areata (AA) is an autoimmune-mediated disorder in which the proximal hair follicle
(HF) attack results in non-scarring partial to total scalp or body hair loss. Despite the growing …